C2i Genomics, Inc. — Form D
C2i Genomics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-08. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-06-08
- Form: D
- Accession: 0001813687-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $12.0M
- Minimum investment: $70K
- Investors: 8
- Date of first sale: 2020-05-22
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-368479
Issuer
- Name: C2i Genomics, Inc.
- CIK: 0001813687
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 180 VARICK STREET, NEW YORK, NY, 10014
- Phone: 12019360045
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Omri Amirav-Drori | Director | San Francisco, CA |
| Eli Casdin | Director | New York, NY |
| Shaun Rodriguez | Director | South San Francisco, CA |
| Alex Parker | Director | South San Francisco, CA |
| Asaf Zviran | Director | Closter, NJ |
| Asaf Zviran | Executive Officer | Closter, NJ |
| Ezra Sofer | Director | Cresskill, NJ |
| Ezra Sofer | Executive Officer | Cresskill, NJ |
Other filings by this issuer (1)
More